# OnCo record paper-csco-asco-nasopharyngeal-carcinoma-guideline-jco-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-csco-asco-nasopharyngeal-carcinoma-guideline-jco-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-csco-asco-nasopharyngeal-carcinoma-guideline-jco-2021" ;
  schema:name "CSCO and ASCO guideline: chemotherapy in combination with radiotherapy for definitive-intent treatment of stage II to IVA nasopharyngeal carcinoma"@en ;
  schema:description "The joint Chinese and American guideline on when to add chemotherapy to radiotherapy for nasopharyngeal cancer: concurrent cisplatin for most stage II to IVA disease, induction gemcitabine-cisplatin for higher-risk disease, and how to handle patients who cannot take cisplatin."@en ;
  schema:url <https://onco.cc/key-papers/paper-csco-asco-nasopharyngeal-carcinoma-guideline-jco-2021/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.03237>, <https://pubmed.ncbi.nlm.nih.gov/33405943/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.03237> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Chen YP, Ismaila N, Chua MLK, et al." ;
  onco:cancers <https://onco.cc/cancers/locoregionally-advanced-nasopharyngeal-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/gemcitabine-cisplatin/> ;
  onco:journals <https://onco.cc/journals/jco/> .